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A B S T R A C T
Objective: The relationship between iron deﬁciency anemia and febrile convulsions has been examined
in several studieswith conﬂicting results. The authors aimed to evaluate the relation, if any, of iron status
with ﬁrst febrile convulsion.
Methods: In this case–control study, the authors assessed 200 children with a diagnosis of ﬁrst febrile
convulsion, aged between 6 months and 5 years, during March 2005 to September 2006. The control
group consisted of febrile children without convulsion; controls were matched to the cases by gender
and age.
Results: The patients and controls were 22.86  12.86 and 21.91  13.58months ofmean age, respectively.
The amount of RBC, serum iron, and plasma ferritin were signiﬁcantly higher, and TIBC was signiﬁcantly
lower among the cases with ﬁrst febrile convulsions than in the controls. The amount of Hb, Hct, MCV, MCH,
andMCHCwere also higher among cases than controls, but differences were not statistically signiﬁcant. Iron
deﬁciency anemia was less frequent among the cases with febrile convulsion, as compared to the controls,
and its differencewas not statistically signiﬁcant; but there is not a protective effect of iron deﬁciency against
development of febrile convulsion (odd ratio = 1.175). The mean of temperature peak on admission was
signiﬁcantly higher in the febrile convulsion group (38.74  0.76 8C) compared with the controls
(38.2  0.67 8C) (P < 0.0001).
Conclusions: The results of this study suggest that iron deﬁciency anemia was less frequent among the
cases with febrile convulsion, as compared to the controls, and there is not a protective effect of iron
deﬁciency against febrile convulsions.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Febrile convulsions are the most common form of childhood
seizures. The peak incidence is at the age of approximately 18
months. In the United States andWestern Europe, they occur 2–4%
of all children1–8; In Japan, however, 9–10% of all children
experience febrile convulsion,1–9 and rates as high as 14% have
been reported from the Mariana Islands in Guam.1–10
Febrile convulsions have been studied extensively over the past
two decades, and a large body of literature now exists to help
practitioners assess the risks associated with such presenta-
tions.2,11–15 Independent risk factors for febrile convulsions were
height of temperature, history of febrile convulsions in a ﬁrst or in a
higher degree relative, the number of fever episodes per year,
maternal smoking and alcohol consumption during pregnancy,
and perinatal exposure to antiretrovirals.7,12,16,17 Genetic factors* Corresponding author. Tel.: +98 131 7722901.
E-mail address: mashoof@mail.com (M. Mashouf).
1059-1311/$ – see front matter  2009 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2009.01.008contribute signiﬁcantly to the etiology of febrile convulsions.
Family studies have shown that relatives of these patients are at
increased risk compared to the general population.18 Twin studies
have also indicated that genetic factors play an important role in
susceptibility to febrile convulsion.19 Segregation patterns in
families with febrile convulsions suggest different modes of
inheritance. Most studies have supported a polygenic or multi-
factorial model, with an estimated heritability of 75%.20–22
However, in families of probands with multiple febrile convul-
sions, the inheritance pattern was consistent with a single-major-
locus model that best ﬁt autosomal dominance with a disease
penetrance of 65%. Linkage analysis studies identiﬁed ﬁve
chromosomal loci for febrile convulsion: FEB1 at 8q13-q21,
FEB2 at 19p, FEB3 at 2q23-q24, FEB4 at 5q14-q15 and FEB5 at
6q22-q24.23–27 In some families, febrile convulsion is present as
part of a broader phenotypic spectrum that also includes atypical
febrile seizures (FS+) and afebrile generalized and partial seizures
i.e. generalized epilepsy with febrile seizures plus (GEFS+).28 In
GEFS+ families, mutations were identiﬁed in SCN1B on chromo-
some 19p13.1 (GEFS+1), SCN1A on chromosome 2q24 (GEFS+2)vier Ltd. All rights reserved.
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phenotype within the GEFS+ families with identiﬁed mutations
segregated in an autosomal dominant pattern with reduced
disease penetrance. Mutations in these three genes were found
in several GEFS+ families, but in most families the causal gene has
not yet been identiﬁed.33 In a large family with febrile convulsion
and familial temporal lobe epilepsy (TLE) a locus was found on
chromosome 12q22-q23.3.34 Risk factors associated with a
complex ﬁrst febrile convulsion were age of 15 months or less,
birth weight of 2 kg or less, and initial temperature of 38 8C or
less35; but despite these studies the risk factors remain largely
unknown.7
Iron deﬁciency is reported to be one of the most prevalent
nutritional problem in the world today, especially in developing
countries, with an estimated 5 billion people so afﬂicted,36 and
iron deﬁciency anemia is a very common nutritional insult among
human infants, especially between 6 and 24 months.37–41 In
developing countries 46–66% of children under 4 years are anemic,
with half attributed to iron deﬁciency anemia. In the United States,
the prevalence of dietary iron deﬁciency has markedly declined in
infants in the last 30 years, but poor, minority, and/or immigrant
infants and toddlers remain at increased risk. There are no accurate
statistics of prevalence of iron deﬁciency anemia in Iranian
children, but it estimated about 20%.42,43 Foods rich in iron are less
available in the diet of poor families, especially in the developing
countries. In Iran, supplemental iron in the form of ferrous sulfate
recommends at the dose of 3 mg/kg/day by 6 months for all full-
term infants, as a routine dietary measure, for 1–2 years.
Among the numerous biological effects of iron, there is
considerable evidence that iron is also important for neurological
functioning.36,44–50 Such functions include neurotransmitter meta-
bolism,51–53myelin formation,54 and brain energymetabolism.55–58
In the rodent model, iron deﬁciency affects regional monoamine
metabolism, in part through iron-dependent enzymes such as
tryptophan hydroyxlase (for serotonin) and tyrosine hydroxylase
(for dopamine and norepinephrine).59 Recent research shows that
iron deﬁciency also results in elevations in extracellular dopamine
and norepinephrine and reductions in D1 and D2 receptors and all
monoamine transporters.60–62 Irondeﬁciencydecreased the expres-
sion of cytochrome c oxidase, a marker of neuronal metabolic
activity.63 Serial neurometabolic assessment of the hippocampus in
the iron deﬁcient rat pup showed elevations in intracellular
glutamate, phosphocreatine, and phosphoryl-ethanolamine con-
centrations.64 Gestational iron deﬁciency induced changes in the
dendritic structure, as assessed bymicrotubule associated protein 2
expression. The role of iron in myelination of the rodent brain has
been known for several decades.54,62 Potential explanations include
fundamental changes to early preoligodendrocyte and oligoden-
drocyte populations and altered regulation of oligodendrocyte iron
uptake via transferrin and transferrin receptors.65,66 Most human
studies on developmental and behavioral effects of iron deﬁciency
focus on the infancy period of peak prevalence, which is 6–24
months. Iron deﬁciency anemia patients have shown an altered
rapid eye movement density in active sleep,67 poorer recognition
memory with event-related potentials,68 and altered electroence-
phalographic frontal asymmetry.69 Affective changes in iron
deﬁciency anemia infants, such as wariness, hesitance, decreased
positive effect, and social interaction, are seen. Recent studies of
auditory evoked potential changes in iron deﬁcient infants point to
possible irreversibly slowedcentral processing.70,71Abasicprinciple
of fetal/neonatal iron biology is that iron is prioritized to red cells at
the expense of other tissues, including brain.When iron supply does
notmeet irondemand, the fetal brainmaybeat riskeven if the infant
is not anemic.72
Evidence that iron might be important for neurological func-
tioning has generated considerable optimism that this materialmight also play a role in initiation of febrile convulsions. Previous
studies examining the relationship between iron deﬁciency
anemia and febrile convulsions have been conﬂicting.7,73–75
Pisacane et al.7 reported that anemia was more common in chi-
ldren younger than 2 years with febrile convulsions, whereas, in
contrast, Kobrinsky et al.73 reported that iron deﬁciency raises the
threshold for seizures.
The purpose of the present study was to assess the relation, if
any, of iron status with ﬁrst febrile convulsion.
2. Materials and methods
The study group consisted of all childrenwith a diagnosis of ﬁrst
febrile convulsion (FFC), aged between 6 months and 5 years,
without history of previous convulsion, developmental delay,
neurological deﬁcit, or CNS infection. Patients were treated at
Rasht 17th Shahrivar Hospital, a referral pediatric center in the
north of Iran associated with the Department of Child Neurology,
during March 2005 to September 2006. The control group
consisted of febrile children without convulsion or previous
history of convulsion, visited in the outpatient pediatric clinic of
the hospital, none of them needed for hospital admission on the
ﬁrst visit, but subsequently 26 patients of this control group
needed for hospitalization in the course of their disease (25
pneumonia and 1 Kawasaki disease); controls werematched to the
cases by gender and age (within 1month for children younger than
1 year, and 2 months for children older than 1 year), family history
of afebrile seizures, temperature at presentation, white blood cell
count, differential, nutrition and antibiotic use. All cases and
controls were with normal growth. Demographic information
collected for cases and controls included age, and gender. Age (in
months and years) was calculated from the date of birth.
Information on birth weight and current weight, developmental
milestones, body temperature upon admission, cause of fever,
history of iron supplement therapy, family history of febrile
convulsion, and family history of epilepsy were recorded for all
cases and controls, as well as details of the seizure history,
duration, frequency, type of seizure (simple or complex), and
duration between initiation of fever and convulsion for cases with
FFC. A single seizure of <15 min duration in the presence of fever
without focal features was deﬁned as a simple febrile convulsion,
whereas seizures were deﬁned as complex if they lasted >15 min,
had focal features, or occurred more than once in 24 h. We used
Acetaminophen, 10–15 mg/kg/dose every 4–6 h, for its antipyretic
effects, for all cases and controls with body temperature higher
than 38.5 8C.
Routine hematological investigations after collection of blood
samples with 6 h of fasting were performed for all patients on
8:00 am at subsequent day of outpatient visit for controls and of
hospital admission for cases, if there was not history of any iron
supplement therapy for previous 3 days. Red blood cell count
(RBC), hemoglobin (Hb), Hematocrit (Hct), mean corpuscular
volume (MCV), mean corpuscular hemoglobin (MCH), mean
corpuscular hemoglobin concentration (MCHC), serum iron con-
centration, total iron binding capacity (TIBC), and plasma ferritin
(PF) were collected for each patient. PF level was measured by
using the IMx Ferritin assay in a microparticle enzyme immu-
noassay (MEIA) for quantitative determination of human PF. We
collected MCV, MCH, and MCHC for exclusion of other types of
anemia, such as thalassemia, because Iran is one of the countries
that located on the thalassemic belt. On the coasts of Caspian sea,
on the north of Iran, rate of carriers is about 10%; in the other parts
of Iran, this rate is between 4% and 8%.76
Iron deﬁciency anemia was deﬁned as decrease of the Hb and
Hct below 2 standard deviation (S.D.) of normal values for age
group, as presence of Hb < 10.5 g% for 6–24 months and <11.5 g%
Table 1
Baseline characteristics of two groups.
Cases (n = 200) Controls (n = 200) Total
No. % No. %
Age (months)
6–12 37 18.5 39 19.5 76
12–24 94 47 86 43 180
24–36 32 16 41 20.5 73
36–48 22 11 17 8.5 39
48–60 7 3.5 9 4.5 16
60–72 8 4 8 4 16
Underlying illness
Upper respiratory
tract infection
121 60.5 26 13 147
Pneumonia 5 2.5 33 11.5 38
Gastroenteritis 42 21 117 58.5 159
Infectious
mononucleosis
1 0.5 3 1.5 4
Vaccination 7 3.5 1 0.5 8
Acute otitis media 5 2.5 2 1 7
Mumps 1 0.5 0 0 1
Kawasaki disease 0 0 1 0.5 1
Urinary tract
infection
0 0 1 0.5 1
Unknown 18 9 14 7 32
Simple seizure
(n = 132–66%)
Complex seizure
(n = 68–34%)
Age group (months)
6–12 23 (17.4%) 14 (20.6%) 37
12–24 65 (49.2%) 29 (42.6%) 94
24–36 22 (16.7%) 10 (14.7%) 32
36–48 15 (11.4%) 7 (10.3%) 22
48–60 7 (5.3%) 8 (11.8%) 15
Duration
<1 h 20 (15.1%) 18 (26.5%) 38
1–24 h 96 (72.7%) 34 (50%) 130
>24 h 16 (12.1%) 16 (23.5%) 32
Table 2
Comparison of cases and controls.
Cases (n = 200) Control (n = 200) P-value
Mean Hb (g%) 10.48  1.16 10.29  1.25 0.114
Mean Hct (%) 32.5  2.91 32.1  3.14 0.145
Mean RBC 4.18  106 4.07  106 0.019
Mean MCV (ﬂ) 77.54  6.63 77.36  6.00 0.75
Mean MCH (pg) 25.24  2.93 25.05  2.25 0.487
Mean MCHC (g%) 32.00  2.21 31.95  1.58 0.774
Mean serum iron (mg/dl) 58.55  35.35 49.75  22.39 0.003
Mean TIBC (mcg/dl) 320.89  49.4 336.28  50.06 0.002
Mean PF (mg/l) 100.23  114.23 75.27  50.80 0.005
Iron deﬁciency anemia 88 (44%) 96 (48%) 0.483
Family history of epilepsy 95 (47.5%) 32 (16%) <0.0001
Iron supplement therapy 167 (83.5%) 169 (84.5%) 0.785
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24–60months old, MCV < 70 ﬂ for 6–24months and<75 ﬂ for 24–
60 months old, MCH < 23 pg for 6–24 months and <24 pg for
24–60months old, MCHC < 30 g% for 6–24months and<31 g% for
24–60 months old, RBC < 3.7  106 for 6–24 months and
<3.9  106 for 24–60 months old, serum iron concentration
<40mg/dl before 1 year old and < 50 mg/dl after 1 year old,
PF < 7 mg/l, and TIBC > 430 mcg/dl.77
A pilot study on 60 patients (30 cases and 30 controls) was
performed for sample size estimation. Based on a = 0.05 and study
power (1–b) = 0.8, and 17 anemic patients in controls (P1 = 0.56)
and 12 anemic patients in cases group (P2 = 0.40):
n ¼ ðZ1a=2 þ Z1bÞ
2½P1ð1 P1Þ þ P2ð1 P2Þ
ðP1  P2Þ2
¼ ð1:96þ 1:28Þ
2½ð0:56 0:44Þ þ ð0:4 0:6Þ
ð0:56 0:4Þ2
 200
We obtained written informed consent from all parents for
inclusion in the study. The Ethics Committee at Guilan University
of Medical Sciences (GUMS) approved the study.
Discrete variables are expressed as counts (%) and compared
using the Chi-square tests. Continuous variables are expressed as
mean  S.D. and compared by means of the unpaired, two-sided t-
test. Adjusted odds ratios and 95% Wald conﬁdence intervals were
calculated based on these models. Statistical signiﬁcance was set at
P < 0.05.
3. Results
Therewere a total of 200 patients and 200 controls. The patients
and controls were 22.86  12.86 and 21.91  13.58 months of mean
age, respectively. Both patients and the controls had a similar
proportion of males (57.5% vs. 59%) and females (42.5% vs. 41%).
Upper respiratory tract infections and gastroenteritis were the
most frequent underlying illnesses for fever in cases and controls,
respectively, which was not signiﬁcantly different between
underlying disease and initiation of seizure (Table 1).
The distribution of seizure types between age groups in cases
with FFC shows in Table 1, also. Seizure was most frequent on 12–
24months of age, and simple seizurewas themost frequent type of
seizures in all but 48–60 months of age groups. There was not
statistically signiﬁcant relationship between age groups and
seizure types (P = 0.556).
The mean of temperature peak on admission was signiﬁcantly
higher in the FFC group (38.74  0.76 8C) compared with the
controls (38.2  0.67 8C) (P < 0.0001). Table 1 shows the time interval
between initiation of the fever and the seizure attack in the patients
with FFC.
Simple seizure was the most frequent type of seizures in all
groups, and the relationship between duration of initiation of fever
and type of convulsion attacks for cases with FFC was statistically
signiﬁcant (P = 0.014).
Data on the patient’s hematologic status are provided in
Table 2; as shown in the table, the amount of RBC, serum iron, and
PF were signiﬁcantly higher, and TIBC was signiﬁcantly lower
among the cases with FFC than in the controls. The amount of Hb,
Hct, MCV, MCH, and MCHC were also higher among cases than
controls, but differences were not statistically signiﬁcant.
Family history of febrile convulsion or epilepsy, iron supple-
ment therapy, and presence of iron deﬁciency anemia among cases
and controls are detailed in Table 2. Iron deﬁciency anemia was
less frequent among the cases with FFC, as compared to the
controls, and its difference was not statistically signiﬁcant. A
signiﬁcantly higher proportion of children from the FFC group had
a family history of epilepsy (P < 0.0001).4. Discussion
As dietary habits of childrenwould have an important inﬂuence
on iron intake, all of our participants had breast or formula feeding
until 6 months of age; solid foods such as cereals, rice and carrot
soup with meat and gradual addition of vegetables, potatoes and
lentil started at this age; egg yolk added on 7 months with
additional fruit juices (apple, banana, lemon, etc.). Most infants
naturally adapt themselves to a schedule of three meals a day by
about the end of the ﬁrst year of life.
There is a controversy regarding the role of ‘‘iron status’’ in the
FFC. Pisacane et al.7 in a case–control studywith 146 cases and 293
controls, with age of 6–24 months, reported a signiﬁcantly higher
rate of iron deﬁciency anemia among children with FFC than in
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result in a case–control study with 30 cases and 30 controls;
whereas Daoud et al.8 in a case–control study with 75 cases and 75
controls demonstrated that only low PF level is associatedwith and
may play a role in FFC, with lack of signiﬁcant differences in Hb,
MCV, and MCH; in contrast, Kobrinsky et al.73 in a case–control
studywith 25 cases and 26 controls, showed that anemia raises the
threshold for FFC and iron deﬁciency may protect against the
development of febrile convulsions.
The results of this study demonstrated the signiﬁcantly higher
amount of RBC, serum iron, and PF, and signiﬁcantly lower amount
TIBC among the caseswith FFC than in the controls. It is known that
ferritin is an acute-phase reactant that increases nonspeciﬁcally in
response to any febrile illness8,73; fever, however, was present in
all patients in the two groups, therefore differences in ferritin
concentration between the two groups cannot be explained by
fever. The amount of Hb, Hct, MCV, MCH, and MCHC were also
higher among cases than controls, but differences failed to attain
statistical signiﬁcance. Iron deﬁciency anemia was less frequent
among the cases with febrile convulsion, as compared to the
controls, and its difference was not statistically signiﬁcant. These
results are in contrast with Pisacane et al.,7 Naveed-ur-Rehman
and Billoo,74 and Daoud et al.8 studies, and conﬁrmed Kobrinsky
et al.73 study results; but in contrast with the study of Kobrinsky,
our study failed to demonstrate a protective effect of iron
deﬁciency against development of febrile convulsion, based upon
odd ratio = 1.175. The authors believed that differences between
the results of the present study and the other studies are because of
difference in sample size and using different patient age groups.
A threshold to febrile seizures dependent on the height of the
body temperature has been demonstrated in animals of various
species and in patients with febrile convulsions. The threshold
varies with individuals, and according to age and maturation.
Increased peak temperature upon admission has been reported to
increase the risk of ﬁrst febrile convulsion progressively, a ﬁnding
conﬁrmed in six additional reports reviewed in 196878 and more
recently in 1995 by Berg et al.17; in a study involving 110 children
with febrile convulsions, themean of body temperature at the time
of the seizure was 40.0 8C, and the mean of 101 recordings with
seizures was signiﬁcantly higher than the mean of 51 highest
fevers unassociated with seizures (P < 0.001)79; but some other
studies failed to show the relation between mean peak tempera-
ture on admission for cases and controls8; our study demonstrated
signiﬁcantly higher mean peak temperature upon admission
in the febrile convulsion group compared with the controls
(38.74  0.76 8C vs. 38.2  0.67 8C) (P < 0.0001).
In our study, the majority of febrile convulsions occur between
6 months and 3 years of age, with the mean age of 22.86  12.86
months, like other studies in this era; the same results obtained for
the higher incidence of convulsions in boys than girls80,81 and higher
proportion of children from the febrile convulsion groupwith a family
history of epilepsy.82–84
This study has some limitations. A case–control study might be
misleading if cases were identiﬁed from hospital admissions and
admission to hospital was inﬂuenced not only by the presence and
severity of disease but also by other variables, such as social class.
In general it is better to use incident rather than prevalent cases. In
the present study, the 17th Shahrivar hospital is the only referral
hospital for child neurology cases for a large geographic area in the
north of Iran, with an exclusive clinic and only one child
neurologist for these cases. In general a case–control design might
introduceweaknesses due to selection problems, and difﬁculties in
interpretation of high prevalent problem such as iron deﬁciency.
This design is much more suitable for exposures which are rather
rare. Accordingly, there is a need for further large cohort study for
this problem.Acknowledgments
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